With origins in the 1950s, Carter BloodCare is one of Texas' largest blood centers, providing 300,000 units of life-saving blood and blood components to patients in North, Central, and East Texas annually.
by William Crews, MD Red blood cell genotyping predicts the antigen phenotype of the red cell by analyzing the portion of DNA that codes for red cell proteins/antigens. Carter BloodCare has performed red cell genotype testing for 10 years. Initially we used this testing to phenotype blood donors to increase our “rare unit” inventory. Over…Read More
by Laurie J Sutor, MD, MBA The 31st edition of AABB Standards for Blood Banks and Transfusion Services went into effect on April 1, 2018. There were several changes and additions of note, a few of which are of interest to hospital blood banks. Selected changes are highlighted below. Note that this article does not…Read More
by Lesley Kresie, MD The number of patients requiring a kidney transplant continues to rise each year and the number of organ donors remains insufficient to meet the need. The growing list of patients waiting for an organ has led transplant programs to look at all possible donor options for their patients, such as living…Read More
Carter BloodCare is honored to be a finalist for the D CEO’s 2018 Nonprofit and Corporate Citizenship Awards. There are many deserving finalists in the Organization of the Year category. D CEO and Communities Foundation of Texas are honoring professionals and organizations in the nonprofit world that make a positive impact on the community. They are also honoring…Read More
Confusion frequently arises over the different notifications received from a blood center regarding blood components under suspicion. This video will attempt to clarify the differences between quarantines, recalls, market withdrawals and lookbacks, the different categories of notification. [embed]https://youtu.be/f1aNPZaSC3Y[/embed]Read More